chr19-44623894-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001205280.2(IGSF23):c.313C>A(p.Gln105Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000322 in 1,550,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001205280.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGSF23 | NM_001205280.2 | c.313C>A | p.Gln105Lys | missense_variant | 2/5 | ENST00000402988.6 | NP_001192209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGSF23 | ENST00000402988.6 | c.313C>A | p.Gln105Lys | missense_variant | 2/5 | 3 | NM_001205280.2 | ENSP00000385592.1 | ||
IGSF23 | ENST00000441389.1 | c.148C>A | p.Gln50Lys | missense_variant | 1/3 | 1 | ENSP00000407344.1 | |||
IGSF23 | ENST00000428245.5 | c.370C>A | p.Gln124Lys | missense_variant | 3/6 | 5 | ENSP00000410629.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000133 AC: 2AN: 150206Hom.: 0 AF XY: 0.0000124 AC XY: 1AN XY: 80678
GnomAD4 exome AF: 0.00000215 AC: 3AN: 1398520Hom.: 0 Cov.: 34 AF XY: 0.00000290 AC XY: 2AN XY: 689778
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2024 | The c.313C>A (p.Q105K) alteration is located in exon 2 (coding exon 2) of the IGSF23 gene. This alteration results from a C to A substitution at nucleotide position 313, causing the glutamine (Q) at amino acid position 105 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at